85
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of the acute and 28-day sub-acute intravenous toxicity of α-l-guluronic acid (ALG; G2013) in mice

ORCID Icon, , , &
Pages 151-160 | Received 22 May 2019, Accepted 03 Sep 2019, Published online: 19 Sep 2019

References

  • Abdalla, Y.O.A., et al., 2018. Acute and 28-day sub-acute intravenous toxicity studies of 1′-S-1′-acetoxychavicol acetate in rats. Toxicology and Applied Pharmacology, 356, 204–213.
  • Afraei, S., et al., 2015. New therapeutic approach by G2013 in experimental model of multiple sclerosis. Acta Neurologica Belgica, 115(3), 259–266.
  • Bjarnason, I., et al., 1993. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology, 104(6), 1832–1847.
  • Bookstaver, P.B., et al., 2010. Intravenous ibuprofen: the first injectable product for the treatment of pain and fever. Journal of Pain Research, 3, 67.
  • Carneiro, M.L., et al., 2015. Acute and subchronic toxicity of the antitumor agent rhodium (II) citrate in Balb/c mice after intraperitoneal administration. Toxicology Reports, 2, 1086–1100.
  • Chaudhary, K., et al., 2010. Intraperitoneal drug therapy: an advantage. Current Clinical Pharmacology, 5(2), 82–88.
  • Cryer, B., 2005. NSAID-associated deaths: the rise and fall of NSAID-associated GI mortality. The American Journal of Gastroenterology, 100(8), 1694.
  • Davis, J.S., et al., 2017. Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic. Open Heart, 4(1), e000550.
  • El Hilaly, J., Israili, Z.H., and Lyoussi, B., 2004. Acute and chronic toxicological studies of Ajuga iva in experimental animals. Journal of Ethnopharmacology, 91(1), 43–50.
  • Fard, N.A., et al., 2017. Efficacy and safety of G2013 as a novel immunosuppressive agent on differentiation, maturation and function of human dendritic cells. Iranian Journal of Public Health, 46(2), 216.
  • Fuedner, T., Heit, H., and Pabst, G., 1990. Evaluation and prediction of chemical toxicity using haematopoietic cell renewal systems. In: P. Bourdeau, E. Somers, G.M. Richardson and J.R. Hickman, eds. Short-term toxicity tests for non-genotoxic effects. Chichester, UK: Wiley, 177–192.
  • Fundueanu, G., et al., 1999. Physico-chemical characterization of Ca-alginate microparticles produced with different methods. Biomaterials, 20(15), 1427–1435.
  • Hajivalili, M., et al., 2015. G2013 modulates TLR4 signaling pathway in IRAK-1 and TARF-6 dependent and miR-146a independent manner. Cellular and Molecular Biology (Noisy-le-Grand, France), 62(4), 1–5.
  • Hosseini, F., et al., 2017. Targeting of crosstalk between tumor and tumor microenvironment by β‐d mannuronic acid (M2000) in murine breast cancer model. Cancer Medicine, 6(3), 640.
  • Howard, M.L., Isaacs, A.N., and Nisly, S.A., 2018. Continuous infusion nonsteroidal anti-inflammatory drugs for perioperative pain management. Journal of Pharmacy Practice, 31(1), 66–81.
  • Huebsch, N. and Mooney, D.J., 2009. Inspiration and application in the evolution of biomaterials. Nature, 462(7272), 426.
  • Jin, J., 2015. JAMA PATIENT PAGE. Nonsteroidal anti-inflammatory drugs. JAMA, 314(10), 1084–1084.
  • Kluwe, W.M., 1981. Renal function tests as indicators of kidney injury in subacute toxicity studies. Toxicology and Applied Pharmacology, 57(3), 414–424.
  • Kunimatsu, T., et al., 2004. Evaluation for reliability and feasibility of the draft protocol for the enhanced rat 28-day subacute study (OECD Guideline 407) using androgen antagonist flutamide. Toxicology, 200(1), 77–89.
  • Laine, L., et al., 2002. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology, 123(4), 1006–1012.
  • Laine, L., et al., 2006. Systematic review: the lower gastrointestinal adverse effects of non‐steroidal anti‐inflammatory drugs. Alimentary Pharmacology and Therapeutics, 24(5), 751–767.
  • Mirshafiey, A. and Rehm, B. H., 2009. Alginate and its comonomer mannuronic acid: medical relevance as drugs. Alginates: biology and applications. Heidelberg, Germany: Springer, 229–260.
  • Mirshafiey, A., et al., 2016. Anti-aging property of G2013 molecule as a novel immunosuppressive agent on enzymatic and non-enzymatic oxidative stress determinants in rat model. Current Drug Discovery Technologies, 13(1), 25–33.
  • Nazeri, S., et al., 2017. Preclinical and pharmacotoxicology evaluation of α-l-guluronic acid (G2013) as a non-steroidal anti-inflammatory drug with immunomodulatory property. Immunopharmacology and Immunotoxicology, 39, 59–65.
  • Rahman, H.S., et al., 2014. Acute toxicity study of zerumbone-loaded nanostructured lipid carrier on BALB/c mice model. BioMed Research International, 2014, 1.
  • Sato, S-i., et al., 1989. A comparison of intraperitoneal injection and oral gavage in the micronucleus test with mitomycin C in mice. Mutation Research/Genetic Toxicology, 223(4), 387–390.
  • Shafaei, A., et al., 2015. Genotoxicity, acute and subchronic toxicity studies of nano liposomes of Orthosiphon stamineus ethanolic extract in Sprague Dawley rats. BMC Complementary and Alternative Medicine, 15(1), 360.
  • Smith, K.J. and Lassmann, H., 2002. The role of nitric oxide in multiple sclerosis. The Lancet. Neurology, 1(4), 232–241.
  • Sostres, C., Gargallo, C.J., and Lanas, A., 2013. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Research and Therapy, 15(3), S3.
  • Southworth, S.R., et al., 2015. An integrated safety analysis of intravenous ibuprofen (Caldolor®) in adults. Journal of Pain Research, 8, 753.
  • Turner, P.V., et al., 2011. Administration of substances to laboratory animals: routes of administration and factors to consider. Journal of the American Association for Laboratory Animal Science, 50(5), 600–613.
  • US Department of Health and Human Services. 2010. Guidance for industry: M3 (R2) nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals. White Oak, MD: US Food and Drug Administration.
  • Williams, D.F., 2009. On the nature of biomaterials. Biomaterials, 30(30), 5897–5909.
  • Zhu, J., et al., 2013. Comparison of toxicity of benzene metabolite hydroquinone in hematopoietic stem cells derived from murine embryonic yolk sac and adult bone marrow. PLoS One, 8(8), e71153.
  • Zimmermann, M., 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain, 16(2), 109–110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.